Protara Therapeutics, Inc. Increase (Decrease) in Other Operating Assets
Protara Therapeutics, Inc. (TARA) reported Increase (Decrease) in Other Operating Assets of $2.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-11
- Protara Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was -$60.00K.
- Protara Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $3.03M.
- Protara Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$60.00K, a 109.49% decline year-over-year.
- Protara Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was -$58.00K.
- Protara Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2025 was -$322.00K, a 198.17% decline from fiscal 2024.
- Protara Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2024 was $328.00K, a 85.74% decline from fiscal 2023.
- Protara Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2023 was $2.30M.
- Protara Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2022 was -$222.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $2.97M 10-Q · filed 2026-08-11 | $2.91M derived: sum of 3 quarters · filed 2026-08-11 | $2.85M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $3.03M 10-Q · filed 2026-05-13 | $2.97M derived: sum of 2 quarters · filed 2026-05-13 | $2.91M derived: sum of 3 quarters · filed 2026-05-13 | $2.83M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$118.00K derived: sum of 2 quarters · filed 2026-03-10 | -$198.00K derived: sum of 3 quarters · filed 2026-08-11 | -$322.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | -$58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$138.00K derived: sum of 2 quarters · filed 2026-08-11 | -$262.00K 10-Q · filed 2025-11-10 | $370.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$204.00K 10-Q · filed 2026-08-11 | $428.00K derived: sum of 3 quarters · filed 2026-08-11 | $333.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$124.00K 10-Q · filed 2026-05-13 | $508.00K derived: sum of 2 quarters · filed 2026-05-13 | $413.00K derived: sum of 3 quarters · filed 2026-05-13 | -$97.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $632.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $537.00K derived: sum of 2 quarters · filed 2026-03-10 | $27.00K derived: sum of 3 quarters · filed 2026-03-10 | $328.00K 10-K · filed 2026-03-10 |
| 2024-09-30 | -$95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$605.00K derived: sum of 2 quarters · filed 2025-11-10 | -$304.00K 10-Q · filed 2025-11-10 | -$301.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$510.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$209.00K 10-Q · filed 2025-08-11 | -$206.00K derived: sum of 3 quarters · filed 2025-08-11 | -$146.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $301.00K 10-Q · filed 2025-05-08 | $304.00K derived: sum of 2 quarters · filed 2025-05-08 | $364.00K derived: sum of 3 quarters · filed 2025-05-08 | $2.66M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $63.00K derived: sum of 2 quarters · filed 2025-03-05 | $2.36M derived: sum of 3 quarters · filed 2025-03-05 | $2.30M 10-K · filed 2025-03-05 |
| 2023-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.35M derived: sum of 2 quarters · filed 2024-11-12 | $2.30M 10-Q · filed 2024-11-12 | $2.21M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $2.24M 10-Q · filed 2024-08-06 | $2.15M derived: sum of 3 quarters · filed 2024-08-06 | $2.07M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | -$58.00K 10-Q · filed 2024-05-02 | -$149.00K derived: sum of 2 quarters · filed 2024-05-02 | -$226.00K derived: sum of 3 quarters · filed 2024-05-02 | -$202.00K derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | -$91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$168.00K derived: sum of 2 quarters · filed 2024-03-13 | -$144.00K derived: sum of 3 quarters · filed 2024-03-13 | -$222.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | -$77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$53.00K derived: sum of 2 quarters · filed 2023-11-03 | -$131.00K 10-Q · filed 2023-11-03 | -$213.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$54.00K 10-Q · filed 2023-08-03 | -$136.00K derived: sum of 3 quarters · filed 2023-08-03 | -$205.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -$78.00K 10-Q · filed 2023-05-04 | -$160.00K derived: sum of 2 quarters · filed 2023-05-04 | -$229.00K derived: sum of 3 quarters · filed 2023-05-04 | -$308.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | -$82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$151.00K derived: sum of 2 quarters · filed 2023-03-08 | -$230.00K derived: sum of 3 quarters · filed 2023-03-08 | -$295.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | -$69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$148.00K derived: sum of 2 quarters · filed 2022-11-03 | -$213.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$144.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | -$65.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$58.00K 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |